Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for symptoms and quality of life in irritable bowel syndrome
IRCT20190404043159N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in irritable bowel syndrome (IBS) comparing Duloxetine with Placebo (2 arms). Primary endpoints: Anxiety, Depression and 2 more. Started Oct 2020; status: completed.
02
Drugs
duloxetine
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on IRCT20190404043159N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190404043159N1.